Winship's senior leadership together constitutes Its Executive Committee, the major decision-making body of the cancer center. The senior leadership has been assembled over the last decade, with a mission to define Winship's scientific priorities and provide oversight to their implementation. The group is led by Walter J. Curran, Jr., M.D., who was appointed Winship Executive Director in September 2009. Dr. Curran, a highly accomplished cancer physician and researcher, has broad authority over all cancer-related research, clinical and educational activities at Emory University. He led the development of a comprehensive strategic plan for Winship and devotes 50% of his time to Winship leadership and the administration of the Cancer Center Support Grant (CCSG). In October 2009, Dr. Curran appointed Fadlo R. Khuri, M.D., as Deputy Director of Winship, with responsibilities defined to include representing the center director at major university and health care functions and focusing on the scientific success and cross-fertilization of the research programs. Dr. Curran has assembled a highly effective team that includes Diane Cassels, M.S., Executive Administrator;Paul W. Doetsch, Ph.D., Associate Director for Basic Research;Edmund K. Waller, M.D., Ph.D., Associate Director for Clinical Research;Kimberiy Kerstann, Ph.D., Associate Director for Research Administration;Joseph Lipscomb, Ph. D., Associate Director for Population Sciences;and most recently, Deborah W. Bruner, Ph.D., R.N., Associate Director for Outcomes Research. Support is requested for all of the above individuals commensurate with their CCSG responsibilities. In addition, Rein Saral, M.D., an accomplished physician leader, serves as Associate Director for Community Affairs and Outreach, Charles Staley, M.D., a nationally prominent surgical oncologist serves as Associate Director for Clinical Affairs, and Dong M. Shin, M.D., a highly accomplished physician-scientist, is Associate Director for Academic Development. These individuals are supported by institutional funds, and no CCSG funds are requested. This group meets twice monthly and serves as the primary deliberative body that advises the Executive Director on major issues including the allocation of Winship's funds, space, and other resources. The Winship senior leadership has supported the development of a significant number of large multi-investigator grants, including a Head and Neck Cancer SPORE grant, several P01's, a large NASA center grant, and Emory's designation as a member of the NCI Chemical Biology Consortium.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Emory University
United States
Zip Code
Havel, L S; Kline, E R; Salgueiro, A M et al. (2015) Vimentin regulates lung cancer cell adhesion through a VAV2-Rac1 pathway to control focal adhesion kinase activity. Oncogene 34:1979-90
Forghani, Parvin; Khorramizadeh, Mohammad R; Waller, Edmund K (2014) Silibinin inhibits accumulation of myeloid-derived suppressor cells and tumor growth of murine breast cancer. Cancer Med 3:215-24
Smith, Alicia K; Conneely, Karen N; Pace, Thaddeus W W et al. (2014) Epigenetic changes associated with inflammation in breast cancer patients treated with chemotherapy. Brain Behav Immun 38:227-36
Ha, Shin-Woo; Weitzmann, M Neale; Beck Jr, George R (2014) Bioactive silica nanoparticles promote osteoblast differentiation through stimulation of autophagy and direct association with LC3 and p62. ACS Nano 8:5898-910
Nooka, Ajay K; Johnson, Heather R; Kaufman, Jonathan L et al. (2014) Pharmacoeconomic analysis of palifermin to prevent mucositis among patients undergoing autologous hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 20:852-7
Capaldo, Christopher T; Farkas, Attila E; Hilgarth, Roland S et al. (2014) Proinflammatory cytokine-induced tight junction remodeling through dynamic self-assembly of claudins. Mol Biol Cell 25:2710-9
Sullivan, Harold C; Oprea-Ilies, Gabriela; Adams, Amy L et al. (2014) Triple-negative breast carcinoma in African American and Caucasian women: clinicopathology, immunomarkers, and outcome. Appl Immunohistochem Mol Morphol 22:17-23
Brodie, Seth A; Li, Ge; El-Kommos, Adam et al. (2014) Class I HDACs are mediators of smoke carcinogen-induced stabilization of DNMT1 and serve as promising targets for chemoprevention of lung cancer. Cancer Prev Res (Phila) 7:351-61
Wang, Hongyan; Wang, Ya (2014) Heavier ions with a different linear energy transfer spectrum kill more cells due to similar interference with the Ku-dependent DNA repair pathway. Radiat Res 182:458-61
Jurchenko, Carol; Chang, Yuan; Narui, Yoshie et al. (2014) Integrin-generated forces lead to streptavidin-biotin unbinding in cellular adhesions. Biophys J 106:1436-46

Showing the most recent 10 out of 49 publications